Trade Mark Journal No.2018/016 20 April 2018

UK00003285257 25 January 2018 (5)

Mark 1

BRABIO

Mark 2

brabio

Class 5
Pharmaceutical products namely for the treatment of multiple sclerosis.

MYLAN EMEA SAS

Representative: Cabinet Plasseraud - Vermander Guillaume